Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fischer

Showing results (351-360 of 489) with videos related to

Pageof 49
Sort By:
Molecular Cancer Therapeutics|May 17, 2008
LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cellsDaniel B Lipka, Linda S Hoffmann, Florian Heidel, et al.
Schizophrenia Bulletin Open|August 15, 2024
Associations Between Clinical Insight and History of Severe Violence in Patients With PsychosisThomas Fischer-Vieler, Petter Andreas Ringen, Erling Kvig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 9, 2007
Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patientsSalah-Eddin Al-Batran, Joerg Thomas Hartmann, Florian Heidel, et al.
Plos One|July 21, 2012
Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cellsDaniel B Lipka, Marie-Christine Wagner, Marek Dziadosz, et al.
International Journal of Molecular Sciences|October 16, 2024
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing MiceThomas Fischer, Felix Dietlein, Detlev Bongartz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
Annals of Hematology|September 2, 2011
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cellsFlorian H Heidel, Thomas S Mack, Elena Razumovskaya, et al.
Blood|January 17, 2004
Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemiaThomas Kindler, Frank Breitenbuecher, Andreas Marx, et al.
International Psychogeriatrics|June 28, 2017
A facilitated approach to family case conferencing for people with advanced dementia living in nursing homes: perceptions of palliative care planning coordinators and other health professionals in the IDEAL studyTim Luckett, Lynnette Chenoweth, Jane Phillips, et al.
Leukemia|December 12, 2022
A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patientsGiorgia Massacci, Veronica Venafra, Sara Latini, et al.
Pageof 49

Showing results (351-360 of 489) with videos related to

Sort By:
Pageof 49
Molecular Cancer Therapeutics|May 17, 2008
LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cellsDaniel B Lipka, Linda S Hoffmann, Florian Heidel, et al.
Schizophrenia Bulletin Open|August 15, 2024
Associations Between Clinical Insight and History of Severe Violence in Patients With PsychosisThomas Fischer-Vieler, Petter Andreas Ringen, Erling Kvig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 9, 2007
Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patientsSalah-Eddin Al-Batran, Joerg Thomas Hartmann, Florian Heidel, et al.
Plos One|July 21, 2012
Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cellsDaniel B Lipka, Marie-Christine Wagner, Marek Dziadosz, et al.
International Journal of Molecular Sciences|October 16, 2024
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing MiceThomas Fischer, Felix Dietlein, Detlev Bongartz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
Annals of Hematology|September 2, 2011
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cellsFlorian H Heidel, Thomas S Mack, Elena Razumovskaya, et al.
Blood|January 17, 2004
Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemiaThomas Kindler, Frank Breitenbuecher, Andreas Marx, et al.
International Psychogeriatrics|June 28, 2017
A facilitated approach to family case conferencing for people with advanced dementia living in nursing homes: perceptions of palliative care planning coordinators and other health professionals in the IDEAL studyTim Luckett, Lynnette Chenoweth, Jane Phillips, et al.
Leukemia|December 12, 2022
A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patientsGiorgia Massacci, Veronica Venafra, Sara Latini, et al.
Pageof 49